Short Interest in POXEL FRANCE (OTCMKTS:PXXLF) Increases By 26,900.0%

POXEL FRANCE (OTCMKTS:PXXLF) was the target of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 27,000 shares, anincreaseof26,900.0% from the July 15th total of 100 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

POXEL FRANCE Price Performance

POXEL FRANCE stock opened at $0.25 on Friday. POXEL FRANCE has a one year low of $0.25 and a one year high of $0.25. The business has a fifty day moving average price of $0.25 and a 200-day moving average price of $0.25.

POXEL FRANCE Company Profile

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.